Article
The BRAFT1799A mutation is not associated with occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2015
Wan Han-Feng, Zhang Bin, Yan Dan-Gui, Xu Zhen-Gang
Abstract excerpt
BACKGROUND: The phenomenon of occult carcinoma maybe observed in patients with clinically unilateral papillary thyroid microcarcinoma (PTMC). Although many studies have reported that the BRAFT1799A mutation is associated with aggressive PTMC, the relationship between BRAFT1799A mutation and occult carcinoma is unclear. The aim of this study was to investigate the risk factors, including BRAFT1799A mutation, for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
